FindTrial
Sign In

Study to compare two drugs: fentanyl and dexmedetomidine used to numb the wind pipe to do endoscopy.

Comparison between fentanyl and dexmedetomidine nebulization as adjuvant to lignocaine during awake flexible fiberoptic bronchoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/11/016429
Enrollment
90
Registered
2018-11-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00-J99- Diseases of the respiratory system

Interventions

Intervention1: Dexmedetomidine 1µg/kg to lignocaine 4 ml 4%: dose: Dexmedetomidine 1µg/kg to 4 ml of 4% lignocaine route: nebulisation frequency: once duration: 20 minutes Control Interventio

Sponsors

AIIMSPatna
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA I/II patients Scheduled for elective bronchoscopy diagnostic procedure

Exclusion criteria

Exclusion criteria: 1. Unconscious and uncooperative patients 2. Intubated patient on ventilator, patient need general anaesthesia, 3. Patient on oxygen 4. Allergic to LA, fentanyl, dexmedetomidine 5. Asthmatics 6. Epileptics 7. Coagulation abnormalities 8. Haemodynamic instability, bradyarrhythmias

Design outcomes

Secondary

MeasureTime frame
1. patient satisfaction score 2. additional sedative doses 3. heart rate and mean arterial pressureTimepoint: 1. after 2 hours 2. 60 minutes 3. 60 minutes—

Primary

MeasureTime frame
1.no. of cough reflex 2. no of additional lignocaine sprays requiredTimepoint: 1. 60 minutes 2. 60 minutes—

Countries

India

Contacts

Public ContactDr Poonam Kumari

AIIMS,Patna

drpoonam1981@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026